Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LPA 0:0/18:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004291 AN007136 Metabolomics analysis of Plasmodium falciparum asexual-stage parasites treated with plasmepsin V peptidomimetics - 16 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004186 AN007232 Discovery and Validation of Metabolic Biomarkers for 'Liver Qi Stagnation' and 'Liver-Gallbladder Damp-Heat' Syndromes in Cholelithiasis: Blood untargeted Blood Human Gallstones First Affiliated Hospital of Dalian Medical University LC-MS
ST003390 AN005563 In-depth profiling of biosignatures for Type 2 diabetes mellitus cohort utilizing an integrated targeted LC-MS platform Blood Human Diabetes First Affiliated Hospital of Dalian Medical University LC-MS
ST003349 AN005489 An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - targeted Blood Human First Affiliated Hospital of Dalian Medical University LC-MS
ST003348 AN005484 An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - untargeted Blood Human First Affiliated Hospital of Dalian Medical University LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
  logo